Our knowledge of the genetic causes of deafness is advancing rapidly, raising hopes for better diagnosis and more effective treatment in the near future.
Reacting to the meningococcal ABCWY vaccine approval with Donna Hallas, PhD, PPCNP-BC
Nurse practitioner Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN offers her thoughts on the recent FDA approval of GSK's meningococcal ABCWY vaccine.
Food Insecurity and the Dangers of Infant Formula Dilution
Weekly review: Several key FDA approvals, new puzzler case, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Demystifying Infant Formula
FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment
The federal agency has approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.
Michael Kruer, MD explains genetic testing and cerebral palsy
Genetic research is revealing that up to 35% of cerebral palsy cases have an identifiable genetic cause, leading to earlier diagnoses and potential precision medicine treatments.